Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Longer looks: Fighting antibiotic resistance; a health care arms race video; the HVP debate

We won't stop the rising tide of infections until we develop a new business model to fight them. We are not quite on the brink of some dystopian Victorian future. But every year, the prognosis for infectious-disease patients gets a bit grimmer. … And more-powerful drugs tend to cost more than the old drugs. … Even in the rich world, death from infection still looms; MRSA alone kills thousands every year. And firms are not developing antibiotics as fast as they used to.

16 Sep 2011

Number of breast, cervical cancer cases rose significantly over past 30 years, global study says

"The number of cases and deaths from breast and cervical cancer is rising in most countries across the world, especially in poorer nations where more women are dying at younger ages, according to a global study of the diseases" by researchers from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, Reuters reports.

16 Sep 2011

Breast and cervical cancers on the rise in poor nations

A new global analysis of diseases has revealed that the number of cases and deaths from breast and cervical cancer is rising in most countries across the world, especially in poorer nations where more women are dying at younger ages.

15 Sep 2011

Perry's HPV vaccine order still resonating, health officials slam Bachmann

The controversy over Texas Gov. Rick Perry's 2007 attempt to vaccinate girls against the human papillomavirus, which surfaced again at Monday's GOP presidential candidate debate, grew on Monday as a result of comments by Rep. Michele Bachmann.

15 Sep 2011

Viewpoints: Shredding Bachmann's vaccine argument; 'super' or 'stupor' committee; Bennet on outmoded drug safety rules

Vaccines were the biggest losers in Monday's GOP presidential candidate's debate, specifically those that are intended to prevent cervical cancer. The main route of HPV infection is sex. That's why you need to vaccinate girls before they become sexually active. The vaccines are exceedingly safe, studies show. There have been very few reports of serious problems from them, none proven. It is simply a lie to say they can cause retardation.

15 Sep 2011

Merck issues statement on GARDASIL human papillomavirus vaccine

Merck, known as MSD outside the United States and Canada, issued the following statement on GARDASIL, Merck's vaccine to protect against certain diseases caused by human papillomavirus (HPV) types 6, 11, 16 and 18.

14 Sep 2011

IUDs may protect from cervical cancer

According to the results of an international study, coil contraceptive devices might protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease.

14 Sep 2011

Intrauterine devices may lower risk of cervical cancer among users, study shows

Contraceptive intrauterine devices (IUDs), also called coils, "might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease," according to a study published Tuesday in the journal Lancet Oncology, Reuters reports.

14 Sep 2011

Intrauterine devices may protect against cervical cancer

Intrauterine devices (IUDs) may protect against cervical cancer. This is the conclusion of the broadest epidemiological study to date in which has participated the research group in Viruses and Cancer of IDIBELL, published at The Lancet Oncology.

14 Sep 2011

George W. Bush Institute forms public-private partnership to combat cervical, breast cancers in developing world

The George W. Bush Institute is forming a public-private partnership to use PEPFAR's existing infrastructure of doctors, nurses and clinics to expand screening and treatment of women for cervical cancer and perform breast cancer education in the developing world, the Wall Street Journal reports.

13 Sep 2011

HPV vaccination updates

Texas Governor Rick Perry's GOP rivals sharply criticized him during Wednesday night's debate over his 2007 executive order mandating that teenage girls be vaccinated to prevent cervical cancer. The move had drawn strong opposition at the time from social conservatives and was later overturned by the state Legislature.

9 Sep 2011

Roundup: Scott's plan stalls to outsource Fla. prison health care; Calif. Blue Shield begins issuing credits after profit cap

Florida's plan to outsource health care in the third-largest U.S. prison system to save $30 million has stalled, hindering efforts by Governor Rick Scott and lawmakers to hire private operators for state services. Requests for proposals on the prison work were withdrawn last month less than a week after they were issued.

9 Sep 2011

Fewer doses of Cervarix vaccine may be as efficacious as standard three-dose regimen

Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, according to a new study published September 9 in the Journal of the National Cancer Institute.

9 Sep 2011

Aggressive medical management better than stenting for prevention of recurrent stroke

Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in today's online first edition of the New England Journal of Medicine.

8 Sep 2011

BCH joins MD Anderson's Sister Institution network to provide cancer care

Today, Barretos Cancer Hospital (BCH) in Brazil joined The University of Texas MD Anderson Cancer Center's Sister Institution network. In a signing ceremony at BCH's newly opened Research Institute Against Digestive Cancer (IRCAD-Brazil), MD Anderson provost and executive vice president, Raymond DuBois, M.D., Ph.D., marked the beginning of an alliance that will allow the two institutions to build a number of collaborative research projects and academic interactions.

8 Sep 2011

Youth immunization rates encouraging: CDC report

According to a survey by the Centers for Disease Control and Prevention (CDC) out Monday, more and more American adolescents are receiving recommended vaccines.

6 Sep 2011

Lilly, QIAGEN partner to develop and commercialize companion diagnostic for JAK2 V617F

QIAGEN today announced that it has entered into a partnership with Eli Lilly and Company for the development, manufacturing and commercialization of a molecular companion diagnostic for an early stage investigational compound currently being developed by Lilly. Financial terms of the agreement were not disclosed.

From QIAGEN Manchester Limited 6 Sep 2011

Circumcision rates decline in the US: Study

A new study has shown that circumcision rates among US baby boys have fallen. According to the Centers for Disease Control and Prevention (CDC), which published the study in the Morbidity and Mortality Weekly Report, circumcision rates dropped from around 62 percent in 1999 to 57 percent in 2008.

5 Sep 2011

Teenagers use medicines frequently without receiving targeted information about risks and benefits

A large proportion of teenagers regularly and frequently take some form of medication without receiving targeted information about the risks and benefits, according to a review of current research, to be presented at the annual congress of the International Pharmaceutical Federation.

5 Sep 2011

HPV vaccination drives to prevent cervical cancers

Mexico plans to administer the vaccine against human papillomavirus (HPV), which can cause cervical cancer, to all girls beginning next year, the country's health ministry said Tuesday.

31 Aug 2011

Cervical Cancer News and Research

Further Reading

Longer looks: Fighting antibiotic resistance; a health care arms race video; the HVP debate

Number of breast, cervical cancer cases rose significantly over past 30 years, global study says

Breast and cervical cancers on the rise in poor nations

Perry's HPV vaccine order still resonating, health officials slam Bachmann

Viewpoints: Shredding Bachmann's vaccine argument; 'super' or 'stupor' committee; Bennet on outmoded drug safety rules

Merck issues statement on GARDASIL human papillomavirus vaccine

IUDs may protect from cervical cancer

Intrauterine devices may lower risk of cervical cancer among users, study shows

Intrauterine devices may protect against cervical cancer

George W. Bush Institute forms public-private partnership to combat cervical, breast cancers in developing world

HPV vaccination updates

Roundup: Scott's plan stalls to outsource Fla. prison health care; Calif. Blue Shield begins issuing credits after profit cap

Fewer doses of Cervarix vaccine may be as efficacious as standard three-dose regimen

Aggressive medical management better than stenting for prevention of recurrent stroke

BCH joins MD Anderson's Sister Institution network to provide cancer care

Youth immunization rates encouraging: CDC report

Lilly, QIAGEN partner to develop and commercialize companion diagnostic for JAK2 V617F

Circumcision rates decline in the US: Study

Teenagers use medicines frequently without receiving targeted information about risks and benefits

HPV vaccination drives to prevent cervical cancers

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News